Literature DB >> 28173966

Nutrition interventions in patients with gynecological cancers requiring surgery.

Andreas Obermair1, Marko Simunovic2, Liz Isenring3, Monika Janda2.   

Abstract

OBJECTIVE: Including developing countries, between 20 and 88% of gynecological oncology patients may present with at least mild malnutrition at diagnosis. Significant morbidity and mortality is attributed to malnutrition. Here we reviewed randomized clinical trials of nutritional interventions used to achieve early return to oral diet, enhance recovery from surgery and reduce adverse events in gynecological cancer patients undergoing surgery.
METHODS: Ebscohost (CINAHL+Medline+PsycINFO), Cochrane, Embase, PubMed and Scopus databases were searched for articles published from 2000 onwards. Potentially eligible articles were screened by two reviewers. Length of hospital stay (LOS), postoperative complications, recovery of intestinal function, quality of life (QOL), hematological and immunological parameters were outcome measures of the nutritional interventions.
RESULTS: Seven randomized clinical trials were included in the review. Early clear liquid diet, semiliquid diet, regular diet or immune-enhanced enteral diets were all found to be safe as nutritional interventions. In five of the seven trials significantly better outcomes were observed in the intervention group compared to usual care for one of more of the outcomes intestinal recovery time, LOS, postoperative complications and immunological parameters. However, the nutritional interventions varied greatly between the trials, making it difficult to directly compare their findings. Trial quality was low to moderate. Recommended malnutrition screening and assessment tools and guidelines for treatment are reviewed.
CONCLUSIONS: From the limited findings it would appear that nutritional interventions of early oral feeding and enteral feeding are safe. Receiving nutritional interventions seems to reduce LOS, intestinal recovery time and postoperative complications for some patients. Increasing use of neoadjuvant treatment may reduce the prevalence of patients presenting malnourished for surgery in the future. Crown
Copyright © 2017. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gynecological cancer; Length of hospital stay; Malnutrition; Nutritional intervention; Randomized clinical trial; Surgical outcomes

Mesh:

Year:  2017        PMID: 28173966     DOI: 10.1016/j.ygyno.2017.01.028

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

Review 1.  Pre-treatment sarcopenic assessments as a prognostic factor for gynaecology cancer outcomes: systematic review and meta-analysis.

Authors:  E H Sutton; M Plyta; K Fragkos; S Di Caro
Journal:  Eur J Clin Nutr       Date:  2022-02-22       Impact factor: 4.016

2.  Prognostic significance of the preoperative hemoglobin to albumin ratio for the short-term survival of gastric cancer patients.

Authors:  Ce-Gui Hu; Bai-E Hu; Jin-Feng Zhu; Zheng-Ming Zhu; Chao Huang
Journal:  World J Gastrointest Surg       Date:  2022-06-27

Review 3.  Nutrition in Cancer Patients.

Authors:  Paula Ravasco
Journal:  J Clin Med       Date:  2019-08-14       Impact factor: 4.241

4.  Postoperative C-reactive protein-to-albumin ratio predicts poor prognosis in patients with bladder cancer undergoing radial cystectomy.

Authors:  Kenji Kuroda; Shinsuke Tasaki; Akio Horiguchi; Keiichi Ito
Journal:  Mol Clin Oncol       Date:  2021-01-21

5.  Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.

Authors:  Yinan Jiang; Haifeng Gu; Xiaojing Zheng; Baoyue Pan; Pingping Liu; Min Zheng
Journal:  Pathol Oncol Res       Date:  2021-12-21       Impact factor: 3.201

6.  Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study.

Authors:  Ester Miralpeix; Josep-Maria Sole-Sedeno; Cristina Rodriguez-Cosmen; Alvaro Taus; Maria-Dolors Muns; Berta Fabregó; Gemma Mancebo
Journal:  World J Surg Oncol       Date:  2022-02-23       Impact factor: 2.754

7.  Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.

Authors:  Weiwei Zhang; Kejun Liu; Bin Ye; Weijiang Liang; Yazhou Ren
Journal:  Cancer Med       Date:  2017-11-28       Impact factor: 4.452

8.  Fast-track- recovery surgery with a whey-protein-infused carbohydrate-loading drink pre-operatively and early oral feeding post-operatively among surgical gynaecological cancer patients: study protocol of an open-labelled, randomised controlled trial.

Authors:  Chiou Yi Ho; Zuriati Ibrahim; Zalina Abu Zaid; Zulfitri 'Azuan Mat Daud; Nor Baizura Md Yusop
Journal:  Trials       Date:  2020-06-16       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.